RECCE-111

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameRECCE-111
Drug Alias NameRECCE-111R-111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitorsBacterial proteins inhibitors
TargetsBacterial proteins
Therapy Area/IndicationsStreptococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRecce Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsStreptococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A